Natural Beauty Bio-Technology Limited
NBBTF
$0.06
$0.00-6.90%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 52.47% | 46.34% | 39.82% | 22.68% | 5.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.47% | 46.34% | 39.82% | 22.68% | 5.62% |
| Cost of Revenue | 62.33% | 59.09% | 55.43% | 33.53% | 11.94% |
| Gross Profit | 45.10% | 37.31% | 29.40% | 15.39% | 1.34% |
| SG&A Expenses | 8.89% | 11.61% | 14.66% | 18.93% | 23.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1,908.40% | -28.08% | 158.74% | 134.48% | 109.85% |
| Total Operating Expenses | 27.01% | 29.34% | 32.02% | 26.48% | 20.50% |
| Operating Income | 155.54% | 133.43% | 84.34% | -143.08% | -11,828.76% |
| Income Before Tax | 111.24% | 62.32% | -87.99% | -268.64% | -790.23% |
| Income Tax Expenses | 177.25% | -289.47% | -196.27% | -167.00% | -149.64% |
| Earnings from Continuing Operations | 110.22% | 62.85% | -72.84% | -224.75% | -588.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 110.22% | 62.85% | -72.84% | -224.75% | -588.76% |
| EBIT | 155.54% | 133.43% | 84.34% | -143.08% | -11,828.76% |
| EBITDA | 351.33% | 443.47% | 1,885.09% | -83.41% | -207.90% |
| EPS Basic | 111.94% | 64.44% | -62.50% | -211.76% | -570.00% |
| Normalized Basic EPS | 133.33% | 105.56% | 50.00% | -114.29% | -1,100.00% |
| EPS Diluted | 111.94% | 64.44% | -62.50% | -211.76% | -570.00% |
| Normalized Diluted EPS | 133.33% | 105.56% | 50.00% | -114.29% | -1,100.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |